Impact of Antiphospholipid Antibodies on Thrombin Generation During Sars-CoV2 Infection (TACIT2 Study)
Clinical trial NCT05128760 · UNKNOWN
Trial details
- NCT number
- NCT05128760
- Sponsor
- Central Hospital, Nancy, France
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2022-01-01
- Primary completion
- 2023-12-01
- Enrollment
- 161
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.